E-drug: Fexofenadine to replace terfenadine (cont'd)
---------------------------------------------
There is only one problem with the "old" sedating antihistamines, ie
that they are occasionally mislabelled for other indications to extend
the market, like ketotifen for asthma and mianserin for depression.
That luckily will not happen with the newer non-sedating ones because
they have neither anti-asthmatic nor antidepressive effects. We should
now forget about terfenadine and astemizole and hope that prices will
come down.
Best wishes to all allergic colleagues!
Leo Offerhaus MD PhD
Koedijklaan 1a, NL-1406KW Bussum, the Netherlands
Phone +31-35-6923288 Fax +31-35-6923290
E-mail: LO@EURONET.NL or CompuServe 71530,15
EJCP Only: POB 75552, NL-1070AN Amsterdam
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.